< HOME / case studies
Patient choice platform secures £135k grant
Tomorrow’s Medicines
No items found.
How Inventya Helped

Tomorrow's Medicines developed an independent platform matching patients to clinical trails.

Our experts provided proof-of-market and proof-of-prototype grant applications needed for the company to further develop the platform. As a result, Tomorrow's Medicines won Technology Strategy Board grant funding of £135k. 

Inventya also provided support in the form of market research and analysis, enabling the company to identify and secure a key industrial client.

We love working with people who are dedicated to improving healthcare, and were proud to have helped secure funding for a company with this shared vision.

←back to case studies

"Working with Inventya is a pleasure. They have extremely knowledgeable and helpful staff who are committed to helping companies grow. Their deep understanding of the grant application process and TSB requirements enabled us to present two successful bids and take our business to the next stage of development." - Tomorrow's Medicines

Dr Clare Nolan, CEO